CN112220738A
|
|
Clindamycin phosphate gel composition and preparation method thereof
|
CN112057469A
|
|
Preparation method of compound polyethylene glycol electrolyte powder
|
CN112174799A
|
|
Preparation method of sodium valproate impurity K
|
CN111718485A
|
|
Viscosity of 475mm2/s~525mm2Production method of medicinal dimethyl silicone oil/s
|
CN111000832A
|
|
Oral film containing cetylpyridinium chloride
|
CN110974783A
|
|
Suspension for treating primary biliary cirrhosis and preparation method thereof
|
CN111110697A
|
|
Sodium phosphate powder and preparation method thereof
|
CN110613731A
|
|
Method for improving taste of compound polyethylene glycol electrolyte powder
|
CN110664738A
|
|
Calcium gluconate oral solution and preparation method thereof
|
CN110907543A
|
|
Experimental method for adsorbing bile acid of hydrotalcite chewable tablet
|
CN110585149A
|
|
Preparation method and application of hydrotalcite combined medicine tablet
|
CN110672738A
|
|
Method for measuring content of polyethylene glycol 4000 in compound polyethylene glycol electrolyte powder
|
CN110613682A
|
|
Doxofylline injection and preparation method thereof
|
CN110575443A
|
|
Doxofylline sustained release tablet and preparation method thereof
|
CN109470646A
|
|
A kind of content assaying method of dimeticone powder
|
CN109470697A
|
|
Natrium adetate detection method in a kind of Mesalazine enema fluid
|
CN110133118A
|
|
A kind of related substance-measuring method of Mesalazine enteric-coated sustained-release tablet
|
CN109528644A
|
|
A kind of Zinc calcium gluconate oral solution and preparation method thereof
|
CN109799292A
|
|
A kind of related substance-measuring method of Mesalazine enema fluid
|
CN109470797A
|
|
A kind of Mesalazine enteric-coated sustained-release tablet release HPLC detection method
|